Artemis Therapeutics Competitors and Similar CompaniesClear all
Artemis Therapeutics's competitors and similar companies include UCB.
 Artemis Therapeutics Artemis Therapeutics (formerly known as New York Global Innovations) is a biopharmaceutical company that engages in the development of agents for the prevention and treatment of severe and potentially life-threatening infectious diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1997 | Founding Date 1928 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations New York, US HQ San Diego, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 1 | Employees 9,052 |
Financial | ||
Revenue (est.) | Revenue (est.) $311k (FY, 2022) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $54k (FY, 2022) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $257k (FY, 2022) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($1.4m) (FY, 2022) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company